These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37758412)
21. Systemic mastocytosis: A cohort study on clinical characteristics of 136 patients in a large tertiary centre. Hermans MAW; Rietveld MJA; van Laar JAM; Dalm VASH; Verburg M; Pasmans SGMA; Gerth van Wijk R; van Hagen PM; van Daele PLA Eur J Intern Med; 2016 May; 30():25-30. PubMed ID: 26809706 [TBL] [Abstract][Full Text] [Related]
24. Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients. Boehm T; Reiter B; Ristl R; Petroczi K; Sperr W; Stimpfl T; Valent P; Jilma B Allergy; 2019 Mar; 74(3):583-593. PubMed ID: 30418682 [TBL] [Abstract][Full Text] [Related]
25. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels. Biedermann T; Ruëff F; Sander CA; Przybilla B Br J Dermatol; 1999 Dec; 141(6):1110-2. PubMed ID: 10606862 [TBL] [Abstract][Full Text] [Related]
26. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. Bonadonna P; Perbellini O; Passalacqua G; Caruso B; Colarossi S; Dal Fior D; Castellani L; Bonetto C; Frattini F; Dama A; Martinelli G; Chilosi M; Senna G; Pizzolo G; Zanotti R J Allergy Clin Immunol; 2009 Mar; 123(3):680-6. PubMed ID: 19135713 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Schwartz LB Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288 [TBL] [Abstract][Full Text] [Related]
28. The problem of anaphylaxis and mastocytosis. Müller UR; Haeberli G Curr Allergy Asthma Rep; 2009 Jan; 9(1):64-70. PubMed ID: 19063827 [TBL] [Abstract][Full Text] [Related]
29. Anaphylaxis and Mast Cell Disorders. Gülen T; Akin C Immunol Allergy Clin North Am; 2022 Feb; 42(1):45-63. PubMed ID: 34823750 [TBL] [Abstract][Full Text] [Related]
30. Systemic mastocytosis presenting as intraoperative anaphylaxis with atypical features: a report of two cases. Bridgman DE; Clarke R; Sadleir PH; Stedmon JJ; Platt P Anaesth Intensive Care; 2013 Jan; 41(1):116-21. PubMed ID: 23362901 [TBL] [Abstract][Full Text] [Related]
31. The Mastocytosis Society Survey on Mast Cell Disorders: Part 2-Patient Clinical Experiences and Beyond. Russell N; Jennings S; Jennings B; Slee V; Sterling L; Castells M; Valent P; Akin C J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1157-1165.e6. PubMed ID: 30098409 [TBL] [Abstract][Full Text] [Related]
32. Critical care management of systemic mastocytosis: when every wasp is a killer bee. van der Weide HY; van Westerloo DJ; van den Bergh WM Crit Care; 2015 Jun; 19(1):238. PubMed ID: 26036415 [TBL] [Abstract][Full Text] [Related]
33. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience. Gülen T; Hägglund H; Dahlén B; Nilsson G Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252 [TBL] [Abstract][Full Text] [Related]
34. Mimics of Allergy and Angioedema: Scombroid, Mast Cell Activation Disorders, and Hereditary Alpha Tryptasemia. Thomas EG; Thomas DJ Immunol Allergy Clin North Am; 2023 Aug; 43(3):553-568. PubMed ID: 37394259 [TBL] [Abstract][Full Text] [Related]
35. Low Frequency of IgE-Mediated Food Hypersensitivity in Mastocytosis. Jarkvist J; Brockow K; Gülen T J Allergy Clin Immunol Pract; 2020 Oct; 8(9):3093-3101. PubMed ID: 32534147 [TBL] [Abstract][Full Text] [Related]
37. Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome. Giannetti MP; Akin C; Castells M J Allergy Clin Immunol Pract; 2020 Apr; 8(4):1196-1201. PubMed ID: 32276688 [TBL] [Abstract][Full Text] [Related]
38. Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases. Matito A; Álvarez-Twose I; Morgado JM; Sánchez-Muñoz L; Orfao A; Escribano L Int Arch Allergy Immunol; 2011; 156(1):104-11. PubMed ID: 21447966 [TBL] [Abstract][Full Text] [Related]
39. Anaphylaxis and systemic mastocytosis controlled with KIT inhibitors in a patient with metastatic lung adenocarcinoma. Hernandez CL; Lynch DM; Golash AJ; Marquis K; Besz KM; Oxnard G; Rotow J; DeAngelo DJ; Castells M Ann Allergy Asthma Immunol; 2023 Nov; 131(5):668-670. PubMed ID: 37597693 [No Abstract] [Full Text] [Related]
40. Patient-reported disease-specific quality-of-life and symptom severity in systemic mastocytosis. van Anrooij B; Kluin-Nelemans JC; Safy M; Flokstra-de Blok BM; Oude Elberink JN Allergy; 2016 Nov; 71(11):1585-1593. PubMed ID: 27089859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]